Aequus Pharmaceuticals Financial Overview
Aequus Pharmaceuticals's market cap is currently C$663.17K. The company's EPS TTM is C$0.003; its P/E ratio is -0.81; Aequus Pharmaceuticals is scheduled to report earnings on November 28, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
